Non-perturbative, gentle and precise delivery enables us to transport virtually all cargo types into virtually all primary cell types while preserving cell health and function. Efficacious dosage control, multiplexing and even cellular extraction/ sampling are core capabilities.
By overcoming the cell viability and manufacturing challenges plaguing vector-based cell and gene therapy development, NAVAN is actively developing therapies in a broad range of indications with strategic partners.
NanoStraws are a physical, non-perturbative conduit for delivery, or “pipelines” into and out of cells. These conduits provide some of the highest efficacies, widest range of cell types, and variety of cargos available. Facile cellular access is changing how we think about cell manipulation and therapy development while dramatically reducing the challenges of viral-based and electroporation-based cell manufacturing.